Payden & Rygel’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.9M Sell
22,700
-16,900
-43% -$5.65M 0.54% 61
2026
Q2
$13.4M Buy
39,600
+7,800
+25% +$2.5M 1.03% 48
2026
Q1
$9.6M Hold
31,800
– – 0.74% 55
2025
Q4
$11.8M Sell
31,800
-900
-3% -$322K 0.81% 45
2025
Q3
$10.9M Sell
32,700
-34,700
-51% -$11M 0.9% 50
2025
Q2
$21.5M Hold
67,400
– – 1.78% 17
2025
Q1
$18.1M Buy
67,400
+2,600
+4% +$769K 1.56% 23
2024
Q4
$19.2M Sell
64,800
-2,500
-4% -$718K 1.66% 18
2024
Q3
$18.3M Buy
67,300
+300
+0.4% +$74.7K 1.41% 27
2024
Q2
$15.5M Buy
67,000
+2,000
+3% +$463K 1.25% 36
2024
Q1
$14.8M Buy
65,000
+300
+0.5% +$62.2K 0.7% 53
2023
Q4
$12.1M Buy
+64,700
New +$10.4M 0.84% 63
2016
Q1
– Sell
-119
Closed -$8K – 160
2015
Q4
$8K Buy
+119
New +$8.66K ﹤0.01% 203

Other funds holding AXP

Payden & Rygel's AXP Position: Q3 2026 in Review

Payden & Rygel reduced its American Express (AXP) stake by 43% in Q3 2026, selling an estimated $5.65M and leaving 22,700 shares worth $6.9M. The position accounts for 0.54% of the portfolio, ranked #61.

Payden & Rygel first reported a position in AXP in Q4 2015 and has held it in 13 quarters since. The position peaked at $21.5M in Q2 2025. 2,568 funds tracked by Wall St. Rank hold AXP as of Q3 2026.

  • Payden & Rygel held 22,700 shares of American Express worth $6.9M as of Q3 2026.
  • Payden & Rygel sold 16,900 American Express shares in Q3 2026, an estimated $5.65M.
  • American Express made up 0.54% of Payden & Rygel's portfolio in Q3 2026, its #61 holding.
  • Payden & Rygel first reported a position in American Express in Q4 2015 and has held it in 13 quarters since.
  • Payden & Rygel's American Express position peaked at $21.5M in Q2 2025.
  • 2,568 funds tracked by Wall St. Rank held American Express as of Q3 2026.

Based on Payden & Rygel's 13F filing for Q3 2026, filed 28 Oct 2026.